Different Patterns of Foxp3 Gene Expression in Pre-and Post-Transplantation Kidney Biopsies and the Effect of Use Mammalian Target of Rapamycin Inhibitors

Transplant Proc. 2023 Jul-Aug;55(6):1408-1410. doi: 10.1016/j.transproceed.2023.03.074. Epub 2023 May 6.

Abstract

Background: Trafficking of regulatory T cells (Tregs) modulates the inflammatory response after kidney transplantation (KTx). There is scarce information on whether circulating and intragraft Tregs are similarly affected by immunosuppressive drugs and the type of deceased kidney donor.

Methods: FOXP3 gene expression was measured in the pretransplant kidney biopsies (PIBx) from donors who met extended (ECD) and standard (SCD) criteria donors. In the third month after KTx, the patients were divided according to tacrolimus (Tac) or everolimus (Eve) and the type of kidney they had received. FOXP3 gene expression in the peripheral blood (PB) and kidney biopsies (Bx) was analyzed using real-time polymerase chain reaction.

Results: FOXP3 gene expression in the PIBx was higher in ECD kidneys. FOXP3 gene expression in the PB and Bx was greater in Eve- than in Tac-treated patients. However, SCD recipients treated with Eve (SCD/Eve) had higher FOXP3 expression than ECD/Eve.

Conclusion: Pretransplant kidney biopsies from ECD kidneys had higher FOXP3 gene expression than SCD, and the use of Eve may affect the expression of the FOXP3 gene only in SCD kidneys.

MeSH terms

  • Biopsy
  • Everolimus / adverse effects
  • Forkhead Transcription Factors / genetics
  • Gene Expression
  • Graft Survival*
  • Humans
  • Kidney
  • Retrospective Studies
  • Sirolimus* / therapeutic use
  • TOR Serine-Threonine Kinases
  • Tacrolimus / therapeutic use
  • Tissue Donors

Substances

  • Sirolimus
  • Tacrolimus
  • Everolimus
  • Forkhead Transcription Factors
  • TOR Serine-Threonine Kinases